André E. Nel, MD PhD
Affiliations: | David Geffen School of Medicine | University of California, Los Angeles, Los Angeles, CA | |
| California NanoSystems Institute | University of California, Los Angeles, Los Angeles, CA |
Area:
NanoMedicineWebsite:
https://cnsi.ucla.edu/andre-nel-bio/Google:
"André Nel"Bio:
http://hdl.handle.net/10019.1/65416 Thesis (M.D.) -- University of Stellenbosch, 1986.
https://scholar.google.com/citations?user=975yvVwAAAAJ&hl=en
Mean distance: (not calculated yet)
Children
Sign in to add trainee| Bingbing Sun | post-doc | UCLA | |
| Haiyuan Zhang | post-doc | UCLA | |
| Tian Xia | post-doc | 2001- | UCLA |
| Xiang Wang | post-doc | 2008- | UCLA |
| Lijia Luo | post-doc | 2021- | UCLA |
| Xiao Xu | post-doc | 2021- | UCLA |
| Saji George | post-doc | 2008-2011 | UCLA |
| Sijie Lin | post-doc | 2010-2015 | |
| Ruibin Li | post-doc | 2011-2016 | UCLA |
| Vahid Mirshafiee | post-doc | 2016-2018 | UCLA |
| Xiangsheng Liu | post-doc | 2013-2020 | UCLA |
| Kuo-Ching Mei | post-doc | 2018-2020 | UCLA |
| Huan Meng | post-doc | 2008-2021 | UCLA |
| Qi Liu | post-doc | 2017-2021 | UCLA |
| Sean D. Allen | post-doc | 2019-2021 | UCLA |
| Jiulong Li | post-doc | 2019-2021 | UCLA |
| Saborni Chattopadhyay | post-doc | 2021-2023 | UCLA |
| Yu-Pei Liao | research scientist | 2004- | UCLA |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chattopadhyay S, Liao YP, Wang X, et al. (2023) Use of Stromal Intervention and Exogenous Neoantigen Vaccination to Boost Pancreatic Cancer Chemo-Immunotherapy by Nanocarriers. Bioengineering (Basel, Switzerland). 10 |
| Luo L, Wang X, Liao YP, et al. (2023) Correction to "Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy". Acs Nano |
| Xu X, Wang X, Liao YP, et al. (2023) Use of a Liver-Targeting Immune-Tolerogenic mRNA Lipid Nanoparticle Platform to Treat Peanut-Induced Anaphylaxis by Single- and Multiple-Epitope Nucleotide Sequence Delivery. Acs Nano |
| Li J, Diamante G, Ahn IS, et al. (2022) Determination of the nanoparticle- and cell-specific toxicological mechanisms in 3D liver spheroids using scRNAseq analysis. Nano Today. 47 |
| Luo L, Wang X, Liao YP, et al. (2022) Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy. Acs Nano |
| Nel AE, Mei KC, Liao YP, et al. (2022) Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs. Acs Nano |
| Liu Q, Wang X, Liao YP, et al. (2021) Use of a Liver-targeting Nanoparticle Platform to Intervene in Peanut-induced anaphylaxis through delivery of an Ara h2 T-cell Epitope. Nano Today. 42 |
| Li J, Guiney LM, Downing JR, et al. (2021) Dissolution of 2D Molybdenum Disulfide Generates Differential Toxicity among Liver Cell Types Compared to Non-Toxic 2D Boron Nitride Effects. Small (Weinheim An Der Bergstrasse, Germany). e2101084 |
| Lu J, Liu X, Liao YP, et al. (2021) Retraction of "Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway". Acs Nano. 15: 10735 |
| Liu X, Jiang J, Liao YP, et al. (2021) Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2002147 |